STEVEN ORTMAN: Open Payments
NPI 1215529243 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 17 payments from 10 companies in 2025. Trend: 2023 $678 · 2024 $626 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Averitas Pharma Inc. | 3 | $47 |
| ABIOMED | 1 | $45 |
| Saluda Medical Americas, Inc. | 1 | $33 |
| Boston Scientific Corporation | 2 | $31 |
| UCB, Inc. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Valinor Pharma, LLC | 1 | $14 |
Products named: Belbuca, RELISTOR, QUTENZA, Evoke, Bimzelx, Iovera, WATCHMAN, HORIZANT.
Industry payments across OK — which companies pay providers there.
